Cardiac Monitoring & Cardiac Rhythm Management Devices Market Size, Share, Growth, and Industry Analysis, By Type (ECG Devices, Implantable Loop Recorder, Cardiac Output Monitoring, Event Monitors, Defibrillators, Pacemakers, Cardiac Resynchronization Therapy (CRT) Devices) By Application (Home and Ambulatory Care, Hospitals, Other) Regional Forecast From 2025 To 2034

Last Updated: 10 September 2025
SKU ID: 29640612

Trending Insights

Report Icon 1

Global Leaders in Strategy and Innovation Rely on Our Expertise to Seize Growth Opportunities

Report Icon 2

Our Research is the Cornerstone of 1000 Firms to Stay in the Lead

Report Icon 3

1000 Top Companies Partner with Us to Explore Fresh Revenue Channels

CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET OVERVIEW

The global Cardiac Monitoring & Cardiac Rhythm Management Devices Market size stood at USD 23.86 billion in 2025, growing further to USD 35.34 billion by 2034 at an estimated CAGR of 4.46% from 2025 to 2034.

The United States Cardiac Monitoring & Cardiac Rhythm Management Devices Market size is projected at USD 7.82389 billion in 2025, the Europe Cardiac Monitoring & Cardiac Rhythm Management Devices Market size is projected at USD 7.32998 billion in 2025, and the China Cardiac Monitoring & Cardiac Rhythm Management Devices Market size is projected at USD 5.48555 billion in 2025.

The global COVID-19 pandemic has been unprecedented and staggering, with cardiac monitoring & cardiac rhythm management devices market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to the market growth and demand returning to pre-pandemic levels once the pandemic is over. 

Cardiovascular show slow symptoms it is known as silent epidemic. They are estimated to be one of the most expensive health conditions to treat. Cardiac rhythm management devices are not only used to manage and monitor cardiac issues but also have applications in repairing, restoring, and healing cardiac activities.  Cardiac monitors are the devices used for taking irregular heartbeats and recognize rhythm disorder and to determine the accurate course of treatment. They monitor the continuous and irregular heart activity through electrocardiography. Severe regulations, high cost for treatment and practical difficulties will reduce the industry revenue. Furthermore, the reputation is also growing due to the increasing rate of risk factors such as diabetes, hypertension, smoking, and obesity. With rising indication for implantable defibrillator and pacemaker implantation has resulted in enhancing the demand and implementation rate of these cardiac rhythm management device in patients are driving the business development. A defibrillator is a medical device that restores a normal heartbeat by sending an electric pulse or shock to the heart. This device is used to treat cardiac situations such as arrhythmia, a heartbeat that is irregular or that is too slow or too fast. The use of defibrillators is growing due to their ability in handling cardiac arrest. Usage of defibrillators has experienced a substantial growth worldwide during the forecast period. Through smartphone connectivity and linked presentations the devices provide new potential for patient dealings and remote monitoring. Other benefits include patient-friendly design, longer battery life, and MRI compatibility. Participating are fixing their efforts on encouraging R&D. Technological development are supporting the regional market growth. Companies coming up with progressive technological solutions for vacuum coatings for firming their positions.

KEY FINDINGS

  • Market Size and Growth: USD 23.86 billion in 2025, growing further to USD 35.34 billion by 2034 at an estimated CAGR of 4.46% from 2025 to 2034.
  • Key Market Driver: cardiovascular diseases account for over 42.5% of all deaths annually in Europe, driving demand for monitoring and rhythm management devices.
  • Major Market Restraint: High device costs and potential complications during implantation continue to limit adoption in low- and middle-income regions.
  • Emerging Trends: The Asia Pacific region is poised for fast growth, supported by increasing healthcare investments and awareness of early cardiac detection.
  • Regional Leadership: North America dominated the global market in 2024, aided by advanced healthcare infrastructure and digital health adoption
  • Competitive Landscape: Technological advancements such as miniaturized implants, wireless connectivity, and AI-based monitoring are intensifying competitive pressure.
  • Market Segmentation:The cardiac monitoring devices segment 46% the global share in 2024, propelled by mounting prevalence of cardiovascular disease and wearable tech innovations.
  • Recent Development: China’s market is rapidly expanding due to a huge patient pool and supportive government healthcare initiatives.

COVID-19 IMPACT

Pandemic hampered the market due to unexpected disruption in the sector

COVID 19 pandemic has extremely affected the whole world. It caused many unexpected disruption and affected the industry. COVID 19 had negative impact on the market due to economic slowdown, unpredictability in financial sector and high unstable market. The pandemic resulted in decreased demand due to a disrupted supply chain, drop in sales of products, delivery schedules. Travel bans imposed affected business collaboration and partnership. Demand had recently reduced due to travel bans and lockdown during the COVID-19 pandemic. The continuous loss in the business due to the lockdown measures is projected to directly influence the growth of the investments in the market.

LATEST TRENDS

Use of innovative products to boost the market growth

Technological improvement and development will further enhance the presentation of the product, allowing it to obtain a varied range of requests in the market. Technological advancement will improve performance and propel the market growth. Technological advancement with high demand are increasingly setting a force to increase the productivity. Some players focus on product improvement to meet consumer requirements and likings. Constant innovation in manufacturing of products is anticipated to stimulate product demand.

  • In Europe, cardiovascular diseases cause more than 42.5% of all deaths, underscoring critical demand for advanced cardiac device monitoring.
  • Approximately 697 million people aged 60 or older resided in Asia-Pacific in 2023—around 60% of the global elderly population—fuelling demand for rhythm management solutions.

CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SEGMENTATION

By Type Analysis

According to type, the market can be segmented ECG devices, implantable loop recorder, cardiac output monitoring, defibrillators, pacemakers, others.

ECG devices capture the maximum market share through forecast period.

By Application Analysis

According to application, the market can be segmented into hospitals, clinic, others.

Cardiac monitoring & cardiac rhythm management devices market players cover segment as hospitals will dominate the market share during forecast period.

DRIVING FACTORS

Rise in cardiovascular disease to boost the market growth

Increasing elderly population and rising obese population has increased occurrence and incidence of cardiovascular diseases are projected to motivate the cardiac monitoring & cardiac rhythm management devices market. Cardiovascular disease is one of the foremost causes of death. Individuals are affected by hearth attacks and stroke each year which boosts the market development.

Technological advancement and development to upsurge the market.

Technological advancements and innovation activate unique revenue augmenting opportunity which will upsurge the cardiac monitoring & cardiac rhythm management devices market growth. Growing investment in research and development activities and growing awareness about benefits are expected to deliver profitable opportunities for the market. Constant development are one of the trends in the market.

  • Worldwide, conditions like atrial fibrillation, bradycardia, and ventricular tachycardia are becoming more prevalent due to aging and sedentary lifestyles, enhancing reliance on rhythm-management devices.
  • The advent of wearable monitoring technologies is expanding patient access to heart health surveillance, with increasing consumer adoption.

RESTRAINING FACTORS

High cost for diagnosis to hamper the market growth

High cost is hampering development of cardiac monitoring & cardiac rhythm management market. High cost incurred for diagnosis and cardiovascular treatment are depleting the growth. High initial cost, complex procedure and upkeep condition are involved in the restraining factors.

  • High costs and surgical risks of implantable devices restrict patient access, especially in underserved regions.
  • Disparities in healthcare infrastructure limit deployment of advanced rhythm-management technologies in low-resource geographies.

CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET REGIONAL INSIGHTS

North America to dominate the region due to technological development

North America is further expected to witness growth in the cardiac monitoring & cardiac rhythm management devices market share. The region is dominating the market due to well-established healthcare infrastructure, increasing elderly population, prompt implementation of technically advanced products. Inhabitants is likely to suffer from heart disease due to reasons like high obesity, high smoking, and unhealthy lifestyles, which may lead to heart attacks and other related issues. Upsurge in investments by key market players for the R&D undertakings and enlargement of their production abilities and product portfolios are projected to upsurge the growth. The expansion of regional market is being aided by technological developments.

KEY INDUSTRY PLAYERS

Key players focus on partnerships to gain competitive advantage.

The key players are dynamically contributing in strategic events that are aimed at maintaining strong market position and increasing market share by merger, partnerships and others. Key players are motivated to introduce new innovative products. They are spending severely on research and development in order to arise with more new technology so that they can maintain and improve their existing market. The market changes are dynamic such as market expansion, partnership and merger.

  • SCHILLER: SCHILLER is recognized as a prominent global provider of real-time cardiovascular monitoring solutions and has formed strategic partnerships with hospitals and data analytics firms to enhance scalable monitoring offerings worldwide.
  • Cardiac Science: Cardiac Science Corporation (also grouped with ZOLL Medical Corporation) is identified as a major company covered in global cardiac monitoring devices market reports, signifying its established role in device offerings.

List of Top Cardiac Monitoring & Cardiac Rhythm Management Devices Companies

  • SCHILLER
  • Cardiac Science
  • Medtronic
  • St. Jude Medical
  • LivaNova
  • Boston Scientific
  • Philips Healthcare
  • BIOTRONIK
  • GE Healthcare
  • Mortara Instrument

REPORT COVERAGE

The report provides scrutiny and information according to market sectors. Business overview, financial overview, product portfolio, new project launch, recent development enquiry are the factors included in the profile. The report incorporates completely examined and appraised evidence of the noticeable players and their position in the market by methods for various descriptive tools. The report covers national and regional level market size and forecast. The report gives businesses the facility to research new prospect in many areas. The report shows to be an operational tool that players can use to gain a competitive superiority over their opponents and ensure lasting achievement in the market.

Cardiac Monitoring & Cardiac Rhythm Management Devices Market Report Scope & Segmentation

Attributes Details

Market Size Value In

US$ 23.86 Billion in 2025

Market Size Value By

US$ 35.34 Billion by 2034

Growth Rate

CAGR of 4.46% from 2025 to 2034.

Forecast Period

2025TO2034.

Base Year

2024

Historical Data Available

Yes

Regional Scope

Global

Segments Covered

By Type

  • ECG Devices
  • Implantable Loop Recorder
  • Cardiac Output Monitoring
  • Defibrillators
  • Pacemakers
  • Others

By Application

  • Hospitals
  • Clinic
  • Others

FAQs